CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 180 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,179,608 | +156.0% | 624,259 | +215.7% | 1.08% | +146.9% |
| Q2 2023 | $6,709,929 | -55.5% | 197,758 | -52.8% | 0.44% | -54.5% |
| Q1 2023 | $15,089,904 | +1059.0% | 419,397 | +768.2% | 0.96% | +793.5% |
| Q2 2022 | $1,302,000 | -87.6% | 48,304 | -82.2% | 0.11% | -82.4% |
| Q4 2021 | $10,492,000 | +41.8% | 271,533 | +98.2% | 0.61% | +40.0% |
| Q3 2021 | $7,398,000 | +64.2% | 137,032 | +1.7% | 0.44% | +68.5% |
| Q2 2021 | $4,505,000 | – | 134,724 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 2,600,000 | $88,218,000 | 12.13% |
| Octagon Capital Advisors LP | 759,898 | $25,783,339 | 3.59% |
| TSP Capital Management Group, LLC | 251,895 | $8,546,800 | 3.08% |
| ACUTA CAPITAL PARTNERS, LLC | 122,343 | $4,151,098 | 2.81% |
| 5AM Venture Management, LLC | 310,270 | $10,527,461 | 2.62% |
| COMMODORE CAPITAL LP | 631,665 | $21,432,393 | 2.41% |
| RTW INVESTMENTS, LP | 3,463,201 | $117,506,410 | 2.24% |
| Eversept Partners, LP | 785,740 | $26,660,158 | 2.23% |
| Redmile Group, LLC | 1,696,004 | $57,545,416 | 2.21% |
| Affinity Asset Advisors, LLC | 87,031 | $2,952,962 | 1.03% |